Clinical Trial Update: A Comparison of Clarithromycin-based and Furazolidone-based Bismuth-containing Regimens for H. Pylori Eradication [Phase 4]

View source ↗

Summary

Phase 4 trial comparing clarithromycin-based and furazolidone-based bismuth-containing regimens for Helicobacter pylori eradication completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Helicobacter Pylori Infection

Drugs mentioned

• clarithromycin-based regimen (clarithromycin)
• furazolidone-based bismuth-containing regimen (furazolidone)

Snippet

Sponsor: Shandong University | Conditions: Helicobacter Pylori | Phase 4 | Status: COMPLETED